Gastrointestinal symptoms in type 1 Diabetes: Associated with quality of life
Journal Title: International Journal of Medical and Health Research - Year 2018, Vol 4, Issue 10
Abstract
Gastrointestinal symptoms are twice as common in type 1 diabetes and associated with poorer quality of life and glycemic control and quality of life. Lower gastrointestinal symptoms are not well characterized in people with type 1 diabetes, and the effects on quality of life and glycemic control has been studying. This study aimed to determine the prevalence of lower gastrointestinal symptoms and the effects on glycemic control and quality of life, and to investigate for underlying causes.
Authors and Affiliations
Ghassan Khalid AlHarazi, Ameer Taher Mesawa, Jehad Tawfiq Alhussaini, Ahmed Mowafaq Dawoud, Malak Saleh Abdullah, Abrar Hassan Abdullah
Feeling the pulse of pulses: Focus on health issues for educating masses: A Review
Pulses are good source of proteins for the majority vegetarian Indians and in combination with cereals supply all essential amino acids. Pulses are rich in dietary fibre, which helps in decreasing blood cholesterol lev...
Comparative assessment of iron profile in diabetes and control patients
Iron is one of the most important micronutrients for good health and disturbed iron metabolism leads to lipid-protein oxidation and also damages RBC membrane. Various research studies found that the reactive free iron or...
Outcome of neonates born to mothers with premature rupture of membranes
The aim of the study is to evaluate an active conservative management (tocolysis and antibiotics administration) in preterm premature rupture of the membranes (PROM), applied to 215 singleton pregnancies. Pregnancies are...
Spectrum of upper gastrointestinal endoscopy findings in patients with dyspepsia and its relation to alarm symptoms
Background: Dyspepsia is a frequent condition encountered in the outpatient department of gastroenterology and is the most common indication for upper gastrointestinal endoscopy. Aims and Objectives: The aim of this stud...
Reactivation d’une tuberculose pulmonaire sous tocilizumab au cours d’une polyarthrite rhumatoïde
Interleukin-6 blocker therapies are therapeutic breakthrough in rheumatoid arthritis (RA). The occurrence of tuberculosis - common in our Moroccan endemic context - under Tocilizumab has been rarely described. We report...